Related Experiment Video
Updated: Aug 30, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
Youchao Qi1,2,3,4, Guozhen Duan2, Dengbang Wei4
1Department of Veterinary Medicine, College of Agriculture and Animal Husbandry, Qinghai University, Xining 810016, China.
Abstract:
The G-protein-coupled bile acid receptor, Gpbar1 or TGR5, is characterized as a membrane receptor specifically activated by bile acids. A series of evidence shows that TGR5 induces protein kinase B (AKT), nuclear factor kappa-B (NF-κB), extracellular regulated protein kinases (ERK1/2), signal transducer and activator of transcription 3 (STAT3), cyclic adenosine monophosphate (cAMP), Ras homolog family member A (RhoA), exchange protein activated by cAMP (Epac), and transient receptor potential ankyrin subtype 1 protein (TRPA1) signaling pathways, thereby regulating proliferation, inflammation, adhesion, migration, insulin release, muscle relaxation, and cancer development. TGR5 is widely distributed in the brain, lung, heart, liver, spleen, pancreas, kidney, stomach, jejunum, ileum, colon, brown adipose tissue (BAT), white adipose tissue (WAT), and skeletal muscle. Several recent studies have demonstrated that TGR5 exerts inconsistent effects in different cancer cells upon activating via TGR5 agonists, such as INT-777, ursodeoxycholic acid (UDCA), and taurolithocholic acid (TLCA). In this review, we discuss both the 'friend' and 'foe' features of TGR5 by summarizing its tumor-suppressing and oncogenic functions and mechanisms.
Insights
The G-protein-coupled bile acid receptor TGR5 (Gpbar1) influences various cellular processes and is found throughout the body. TGR5 exhibits dual roles in cancer, acting as both a tumor suppressor and an oncogene.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- G-protein-coupled bile acid receptor (Gpbar1), also known as TGR5, is a membrane receptor activated by bile acids.
- TGR5 activation triggers multiple signaling pathways, including AKT, NF-κB, ERK1/2, STAT3, cAMP, RhoA, Epac, and TRPA1.
- This receptor is broadly distributed across various tissues, including the brain, liver, adipose tissue, and digestive system.
Purpose of the Study:
- To review the dual role of TGR5 in cancer development.
- To summarize the tumor-suppressing and oncogenic functions of TGR5.
- To elucidate the mechanisms underlying TGR5's contradictory effects in different cancer cells.
Main Methods:
- Literature review of recent studies on TGR5.
- Analysis of TGR5 signaling pathways and their downstream effects.
- Examination of TGR5 agonist effects (e.g., INT-777, UDCA, TLCA) on cancer cells.
Main Results:
- TGR5 regulates key cellular functions such as proliferation, inflammation, adhesion, migration, and insulin release.
- TGR5 activation by agonists shows inconsistent effects on different cancer cells.
- Evidence suggests both tumor-suppressing and oncogenic activities of TGR5.
Conclusions:
- TGR5 plays a complex and context-dependent role in cancer.
- Understanding TGR5's 'friend' and 'foe' features is crucial for targeted cancer therapies.
- Further research is needed to fully delineate TGR5's mechanisms in tumorigenesis.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

